Functional mutations of estrogen receptor protein: Assay for detection

Breast Cancer Research and Treatment

Volumn 72, Issue 1, 2002, Pages 61-68

  Nichols, Mark ^a   McCarty Jr , Kenneth S ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Antihormones; Coactivators; Color plate assay; Estrogen receptor; FLP recombinase; Helix 12; Hormones; Ligand binding domain; S. cerevisiae

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER DIAGNOSIS; CANCER THERAPY; ENZYME ACTIVITY; ESTROGEN BINDING; GENE MUTATION; HORMONE BINDING; LIGAND BINDING; MARKER GENE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

BIOLOGICAL ASSAY; BREAST NEOPLASMS; DNA NUCLEOTIDYLTRANSFERASES; DNA, NEOPLASM; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; LIGANDS; MUTATION; NEOPLASMS, HORMONE-DEPENDENT; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SACCHAROMYCES CEREVISIAE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 0036212102     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014917131282     Document Type: Article

References (31)

1. AIB-1, a steroid receptor coactivator amplified in breast and ovarian cancer
2. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain
3. Molecular basis of agonism and antagonism in the oestrogen receptor
4. DNA cleavage in trans by the active site tyrosine during Flp recombination: Switching protein partners before exchanging strands
5. Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer
6. Estrogen and progesterone receptor variants in human breast cancer
7. Structure and specificity of nuclear receptor-coactivator interactions
8. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein1 (GRIP1) and steroid receptor coactivator 1 (SRC1): Multiple motifs with different binding specificities
9. Different classes of coactivators recognize distinct overlapping binding sites on the estrogen receptor ligand binding domain
10. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor
11. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
12. Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P- 1 study
13. Estrogen receptor mutations in breast cancer
14. Nuclear receptors enhance our understanding of transcription regulation
15. Transcription factors 3: Nuclear receptors
16. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors
17. Isoforms of the steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor
18. Identification of two transactivation domains in the mouse oestrogen receptor
19. Estrogen receptor variants and mutations
20. FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists
21. Different positioning of the ligand binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists
22. Enhancement of estrogen receptor transcriptional activity by the coactivator GRIP-1 highlights the role of activation function 2 in determining estrogen receptor pharmacology
23. Regulation of protein function through expression of chimaeric proteins
24. Nuclear hormone receptor coregulators in action: Diversity for shared tasks
25. Changes in the structure of the ligand or substitutions to AF2 residues in the estrogen receptor make independent contributions to coactivator sensitivity by SRC-1
26. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
27. CREB binding protein acts synergistically with steroid coactivator-1 to enhance steroid receptor dependent transcription
28. Targeted anti-estrogens to treat and prevent diseases in women
29. The role of estrogen receptor mutations in tamoxifen-stimulated breast cancer
30. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene